PHARMA JAPAN welcomes JETRO New York’s Shunsuke Tani as a guest columnist. In occasional contributions, Tani will share his perspectives on US pharmaceutical policy, industry developments, and life in America, drawing on his firsthand experience in the US.---Hello from New…
HOME > BUSINESS
BUSINESS
- Kowa President Has High Hopes for Livalo Successor Parmodia
July 20, 2017
- Zymeworks Gains US$1 Million from Daiichi Sankyo in Bispecific Antibody Milestone
July 20, 2017
- Hisamitsu Begins New Japan PIII for NSAIDs Patch after Unfavorable PII/III
July 20, 2017
- Takeda-Teva JV to Discontinue Sale of 53 Generic APIs
July 19, 2017
- JCR, Teijin to Codevelop Regenerative Medicine Product, Plan to Begin Clinical Studies in 2018
July 19, 2017
- Sunovion to Divest Asthma and Allergy Products to Focus on COPD
July 18, 2017
- Bayer Yakuhin to Ban Any Type of Medical Affairs Work by Sales Organization
July 18, 2017
- Probe Finds No HQ Instruction for Improper Patient Info Acquisition in Xarelto Surveys, Bayer Execs Take 3-Month Pay Cuts
July 18, 2017
- Nichi-Iko’s Remicade Biosimilar Filed in 2 Routes, Ayumi to Also Market It under Different Trade Name
July 14, 2017
- Ambicion, RIKEN Pair Up for Joint Research to Develop Novel Antiallergics
July 14, 2017
- Debiopharm’s Appeal on Elplat Patent Suit Rejected: Nippon Chemiphar/Nagase
July 13, 2017
- Daiichi Sankyo Links Up with Max Planck Innovation, LDC on Cancer Research
July 13, 2017
- Vemlidy Counterfeit with Japanese Label Found in China
July 13, 2017
- Biogen, Univ. of Tokyo Establish Research Program on “Pharmacotherapeutics for Neuropsychiatric Disorders”
July 13, 2017
- Astellas Pursuing Corrective Measures after ABPI Suspension Extension: CEO
July 12, 2017
- Astellas Eager to Take in External Resources; Key Xtandi Data Out Later This Year
July 12, 2017
- Boehringer Ingelheim, NCC Forge Comprehensive Partnership
July 12, 2017
- Daiichi Sankyo’s Oncolytic Virus Gets Orphan Status
July 12, 2017
- Ethical Drug Sales Tick Up 1.7% in May: Crecon
July 12, 2017
- Mundipharma Inks Partnership with J1 Soccer Team, Isodine Logo Put on Uniform
July 11, 2017
ページ
Japan should fundamentally overhaul its cost-effectiveness assessment (CEA) scheme while putting a hold on CEA-based price adjustments, a new ruling…
Global drug makers are forging ahead with therapies targeting lipoprotein(a), or Lp(a), a promising new approach to reducing cardiovascular risks.…
Japanese Prime Minister Sanae Takaichi said on October 14 that the government will consider the necessary measures for the FY2027…
Eli Lilly’s breast cancer drug Imulrio (imlunestrant) is finally joining Japan’s NHI price list on October 14, nearly 300 days…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…